Literature DB >> 30173638

Evaluation of HIV+ patients experience with pharmaceutical care based on AMO-methodology.

María de Gracia Cantillana-Suárez1, Mercedes Manzano-García2, María de Las Aguas Robustillo-Cortés3, Ramón Morillo-Verdugo4.   

Abstract

OBJECTIVE: To evaluate the experience of HIV+ patients with pharmaceutical care based on the ability-motivation-opportunity methodology. Method: Cross-sectional, unicentric study. The participants included were HIV+  patients attended during November-2016 and to whom the IEXPAC  questionnaire was conducted. This validated questionnaire allows to know the  experience of chronic patients about the health care they receive.
RESULTS: 91 patients were included. The overall mean score of the IEXPAC  questionnaire was: 9.7 ± 0,3. The items that obtained higher scores were:  respect lifestyle (9.9 ± 0.5); coordination to offer good care (9.9 ± 0.5); helping  to continue treatment (9.9 ± 0.4); making sure that I take medication  (9.9 ± 0.4); worried about well-being (9.9 ± 0.4). The points with the possibility  of improvements included: worried about me when I get home after  being in hospital (8.7 ± 1.2).
CONCLUSIONS: The evaluation of the pharmaceutical care process based on the  ability-motivation-opportunity model achieve a high level in each of the  identified points of interaction. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30173638     DOI: 10.7399/fh.10947

Source DB:  PubMed          Journal:  Farm Hosp        ISSN: 1130-6343


  2 in total

1.  A New Pharmaceutical Care Concept: More Capable, Motivated, and Timely.

Authors:  Ramón Morillo-Verdugo; Miguel Ángel Calleja-Hernández; María de Las Aguas Robustillo-Cortés
Journal:  Hosp Pharm       Date:  2019-08-01

2.  Satisfaction and knowledge among patients with HIV after switching from tenofovir to tenofovir alafenamide in regimens containing emtricitabine and rilpivirine

Authors:  Manuel Vélez-Díaz-Pallarés; Teresa Gramage-Caro; Miguel Ángel Rodríguez-Sagrado; Beatriz Montero-Llorente; Teresa Bermejo-Vicedo
Journal:  Biomedica       Date:  2020-05-01       Impact factor: 0.935

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.